Upgrade to SI Premium - Free Trial

Cardlytics (CDLX) Tops Q3 EPS by 42c

November 7, 2024 6:16 PM

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.15), $0.42 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $67.06 million versus the consensus estimate of $57.71 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

Categories

Earnings